Posting fresh info about MS, for people with MS and their supporters

  • HOT off the CMSC Press: Fatigue often the first MS symptom

    MONTREAL — Months or even years before demyelinating events are recognized, patients later diagnosed with multiple sclerosis often turn up in their doctors’ offices complaining of fatigue, [...]


     
  • Stem cell funding ban overturned in the US

    In a 2-1 decision, a panel of the court of appeals in Washington overturned a judge’s order that would have blocked federal financing of stem cell research. [...]


     
  • Scientists Have (Potentially) Discovered the Chemical that Triggers MS

    Scientists are said to have made a major breakthrough as they have found the chemical that enhances the symptoms of multiple sclerosis. The chemical known as granulocyte-macrophage [...]


     
  • FDA details timeframe of Tysabri’s PML risk

    The brain infection risk from Biogen Idec’s multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning [...]


     
  • IF YOU CAN DREAM: Upcoming Documentary Highlights Living and Thriving with MS

    Over half a million Americans have been diagnosed with Multiple Sclerosis. The news can mean a life interrupted, and a dream dashed. Several films have highlighted a [...]


     
Feeds

Search


WELCOME / MS News Today

Thank you so much for visiting. My name is Caroline and I have had MS for about 14 years. I've gathered some articles that I find useful and have introduced each one with a brief comment. Please feel free to leave comments of your own or give suggestions for improvements, content addition, or anything on your mind.

SUPPORT / Find out More


 

TAG / CLOUD

aan, alemtuzumab, avonex, betaseron, biogen, bioms medical corp, campath, ccsvi, cis, cladribine, clarity, cognitive dysfunction, copaxone, daclizumab, dirucotide, discovery, ectrims, elan, fampridine-sr, fatigue, fda, fda fast track status, fingolimod, fty-720, genzyme, gilenia, gilenya, interferons, laquinimod, merck, merck/serono, novartis, oral ms therapies, phase iii, pml, rebif, rrms, serono, smoking, spms, stem cells, teriflunomide, teva, therapy, tysabri

ARCHIVES / PAST ARTICLES



Follow me on Twitter
Friend me on Facebook
Subscribe by Email




Bookmark and Share


Wordpress Engine. Upstart Theme. Better Project.